BioTechne Corp (TECH)
(Delayed Data from NSDQ)
$73.99 USD
-0.53 (-0.71%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $73.99 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
D Value D Growth D Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$73.99 USD
-0.53 (-0.71%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $73.99 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
D Value D Growth D Momentum F VGM
Zacks News
New Strong Sell Stocks for August 30th
by Zacks Equity Research
AMKR, TECH and CIADY have been added to the Zacks Rank #5 (Strong Sell) List on August 30, 2024.
New Strong Sell Stocks for August 28th
by Zacks Equity Research
TECH, AMFPF and B have been added to the Zacks Rank #5 (Strong Sell) List on August 28, 2024.
New Strong Sell Stocks for August 23rd
by Zacks Equity Research
ARCO, BMTX and TECH have been added to the Zacks Rank #5 (Strong Sell) List on August 23, 2024.
Techne (TECH) Misses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Techne (TECH) delivered earnings and revenue surprises of -3.92% and 0.65%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Ultragenyx (RARE) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Ultragenyx (RARE) delivered earnings and revenue surprises of 7.32% and 19.13%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Arvinas (ARVN) Surges 9.2%: Is This an Indication of Further Gains?
by Zacks Equity Research
Arvinas (ARVN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
GMAB or TECH: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
GMAB vs. TECH: Which Stock Is the Better Value Option?
GMAB vs. TECH: Which Stock Is the Better Value Option?
by Zacks Equity Research
GMAB vs. TECH: Which Stock Is the Better Value Option?
5 Stocks at the Forefront of S&P 500 ETF's Latest Rally
by Sweta Killa
The S&P 500 is up for the fourth consecutive session. While many stocks have powered the ETF, we have highlighted five that have led the way higher.
HRMY or TECH: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
HRMY vs. TECH: Which Stock Is the Better Value Option?
Techne (TECH) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
The headline numbers for Techne (TECH) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Techne (TECH) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Techne (TECH) delivered earnings and revenue surprises of 4.35% and 3.77%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Blueprint Medicines (BPMC) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
by Zacks Equity Research
Blueprint Medicines (BPMC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate Techne (TECH) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Techne (TECH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
GSK or TECH: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
GSK vs. TECH: Which Stock Is the Better Value Option?
HRMY vs. TECH: Which Stock Is the Better Value Option?
by Zacks Equity Research
HRMY vs. TECH: Which Stock Is the Better Value Option?
Here's What Key Metrics Tell Us About Techne (TECH) Q2 Earnings
by Zacks Equity Research
Although the revenue and EPS for Techne (TECH) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Techne (TECH) Q2 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Techne (TECH) delivered earnings and revenue surprises of -4.76% and 1.76%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
What Analyst Projections for Key Metrics Reveal About Techne (TECH) Q2 Earnings
by Zacks Equity Research
Beyond analysts' top -and-bottom-line estimates for Techne (TECH), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2023.
GMAB or TECH: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
GMAB vs. TECH: Which Stock Is the Better Value Option?
PBYI or TECH: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
PBYI vs. TECH: Which Stock Is the Better Value Option?
PBYI or TECH: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
PBYI vs. TECH: Which Stock Is the Better Value Option?
PBYI vs. TECH: Which Stock Is the Better Value Option?
by Zacks Equity Research
PBYI vs. TECH: Which Stock Is the Better Value Option?
PBYI or TECH: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
PBYI vs. TECH: Which Stock Is the Better Value Option?
Here's What Key Metrics Tell Us About Techne (TECH) Q1 Earnings
by Zacks Equity Research
The headline numbers for Techne (TECH) give insight into how the company performed in the quarter ended September 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.